To include your compound in the COVID-19 Resource Center, submit it here.

CHMP recommends expanded Humira label for pediatric uveitis

EMA's CHMP recommended expanding the label of Humira adalimumab from AbbVie Inc.

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE